NPs Basic Information
|
Name |
Guignardone V
|
| Molecular Formula | C16H20O5 | |
| IUPAC Name* |
7-acetyl-12-hydroxy-4-methyl-3,14-dioxatetracyclo[10.2.1.02,10.04,8]pentadec-2(10)-en-11-one
|
|
| SMILES |
CC(=O)C1CCC2(C)OC3=C(CC12)C(=O)C1(O)COC3C1
|
|
| InChI |
InChI=1S/C16H20O5/c1-8(17)9-3-4-15(2)11(9)5-10-13(21-15)12-6-16(19,7-20-12)14(10)18/h9,11-12,19H,3-7H2,1-2H3/t9-,11-,12-,15+,16+/m0/s1
|
|
| InChIKey |
QPUANSSRWQEYEB-JMHSHNQBSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
*Note: the IUPAC Name was calculated by STOUT. Reference: PMID:33906675.
Chemical Classification: |
|
|
|---|
——————————————————————————————————————————
NPs Species Source
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
NPs Biological Activity
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
NPs Physi-Chem Properties
| Molecular Weight: | 292.33 | ALogp: | 1.1 |
| HBD: | 1 | HBA: | 5 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 72.8 | Aromatic Rings: | 4 |
| Heavy Atoms: | 21 | QED Weighted: | 0.794 |
——————————————————————————————————————————
NPs ADMET Properties*
ADMET: Absorption
| Caco-2 Permeability: | -4.797 | MDCK Permeability: | 0.00001900 |
| Pgp-inhibitor: | 0.034 | Pgp-substrate: | 0.003 |
| Human Intestinal Absorption (HIA): | 0.01 | 20% Bioavailability (F20%): | 0.003 |
| 30% Bioavailability (F30%): | 0.01 |
——————————————————————————————————————————
ADMET: Distribution
| Blood-Brain-Barrier Penetration (BBB): | 0.695 | Plasma Protein Binding (PPB): | 65.89% |
| Volume Distribution (VD): | 0.805 | Fu: | 36.04% |
——————————————————————————————————————————
ADMET: Metabolism
| CYP1A2-inhibitor: | 0.021 | CYP1A2-substrate: | 0.862 |
| CYP2C19-inhibitor: | 0.049 | CYP2C19-substrate: | 0.832 |
| CYP2C9-inhibitor: | 0.023 | CYP2C9-substrate: | 0.05 |
| CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.155 |
| CYP3A4-inhibitor: | 0.026 | CYP3A4-substrate: | 0.761 |
——————————————————————————————————————————
ADMET: Excretion
| Clearance (CL): | 11.594 | Half-life (T1/2): | 0.313 |
——————————————————————————————————————————
ADMET: Toxicity
| hERG Blockers: | 0.012 | Human Hepatotoxicity (H-HT): | 0.707 |
| Drug-inuced Liver Injury (DILI): | 0.685 | AMES Toxicity: | 0.051 |
| Rat Oral Acute Toxicity: | 0.746 | Maximum Recommended Daily Dose: | 0.739 |
| Skin Sensitization: | 0.438 | Carcinogencity: | 0.562 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.013 |
| Respiratory Toxicity: | 0.045 |
——————————————————————————————————————————
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.
Similar Compounds*
Compounds similar to EMNPD with top10 similarity:
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002719 |  |
0.841 | D0C7JF |  |
0.290 | ||
| ENC003341 |  |
0.764 | D04SFH |  |
0.273 | ||
| ENC002720 |  |
0.686 | D04GJN |  |
0.273 | ||
| ENC006126 |  |
0.671 | D0Q4SD |  |
0.268 | ||
| ENC002721 |  |
0.634 | D06AEO |  |
0.265 | ||
| ENC003340 |  |
0.595 | D0I2SD |  |
0.260 | ||
| ENC003657 |  |
0.595 | D07BSQ |  |
0.258 | ||
| ENC006129 |  |
0.558 | D0F1UL |  |
0.258 | ||
| ENC003344 |  |
0.519 | D0U3GL |  |
0.253 | ||
| ENC003594 |  |
0.455 | D0IL7L |  |
0.252 | ||